BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Val JHD. Old-age inflammatory bowel disease onset: A different problem? World J Gastroenterol 2011; 17(22): 2734-2739 [PMID: 21734781 DOI: 10.3748/wjg.v17.i22.2734] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Ali RA. The positive influences of increasing age at diagnosis of inflammatory bowel disease on disease prognostication in asian perspective. Intest Res 2015;13:4-5. [PMID: 25691837 DOI: 10.5217/ir.2015.13.1.4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Ahmed O, Nguyen GC. Therapeutic challenges of managing inflammatory bowel disease in the elderly patient. Expert Rev Gastroenterol Hepatol 2016;10:1005-10. [PMID: 27087144 DOI: 10.1080/17474124.2016.1179579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ramage L, Qiu S, Georgiou P, Tekkis P, Tan E. Functional outcomes following ileal pouch-anal anastomosis (IPAA) in older patients: a systematic review. Int J Colorectal Dis 2016;31:481-92. [PMID: 26754072 DOI: 10.1007/s00384-015-2475-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
4 Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther 2014;39:459-77. [PMID: 24405149 DOI: 10.1111/apt.12616] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 12.1] [Reference Citation Analysis]
5 Ha CY, Katz S. Clinical outcomes and management of inflammatory bowel disease in the older patient. Curr Gastroenterol Rep 2013;15:310. [PMID: 23307425 DOI: 10.1007/s11894-012-0310-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
6 Ikeuchi H, Uchino M, Matsuoka H, Bando T, Hirata A, Takesue Y, Tomita N, Matsumoto T. Prognosis following emergency surgery for ulcerative colitis in elderly patients. Surg Today 2014;44:39-43. [PMID: 23553422 DOI: 10.1007/s00595-013-0563-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
7 Kassam Z, Belga S, Roifman I, Hirota S, Jijon H, Kaplan GG, Ghosh S, Beck PL. Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis 2014;20:2483-92. [PMID: 25185685 DOI: 10.1097/MIB.0000000000000173] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
8 Scavone C, Sessa M, Clementi E, Corrao G, Leone R, Mugelli A, Rossi F, Spina E, Capuano A. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study. BioDrugs 2018;32:607-17. [PMID: 30341487 DOI: 10.1007/s40259-018-0313-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Chao CY, Duchatellier CF, Seidman EG. Unsuspected Small-Bowel Crohn's Disease in Elderly Patients Diagnosed by Video Capsule Endoscopy. Diagn Ther Endosc. 2018;2018:9416483. [PMID: 29622900 DOI: 10.1155/2018/9416483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Papoutsopoulou S, Satsangi J, Campbell BJ, Probert CS. Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanisms. Aliment Pharmacol Ther 2020;51:1268-85. [PMID: 32372449 DOI: 10.1111/apt.15774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
11 Lobatón T, Ferrante M, Rutgeerts P, Ballet V, Van Assche G, Vermeire S. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther 2015;42:441-51. [PMID: 26104047 DOI: 10.1111/apt.13294] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 12.9] [Reference Citation Analysis]
12 Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K, Kunisaki R, Motoya S, Nagahori M, Nakase H, Omata F, Saruta M, Watanabe T, Tanaka T, Kanai T, Noguchi Y, Takahashi KI, Watanabe K, Hibi T, Suzuki Y, Watanabe M, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53:305-353. [PMID: 29429045 DOI: 10.1007/s00535-018-1439-1] [Cited by in Crossref: 184] [Cited by in F6Publishing: 166] [Article Influence: 46.0] [Reference Citation Analysis]
13 Taleban S. Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly. Curr Treat Options Gastro 2015;13:275-86. [DOI: 10.1007/s11938-015-0059-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
14 Taleban S, Colombel JF, Mohler MJ, Fain MJ. Inflammatory bowel disease and the elderly: a review. J Crohns Colitis. 2015;9:507-515. [PMID: 25870198 DOI: 10.1093/ecco-jcc/jjv059] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 10.1] [Reference Citation Analysis]
15 Schembri J, Bonello J, Christodoulou DK, Katsanos KH, Ellul P. Segmental colitis associated with diverticulosis: is it the coexistence of colonic diverticulosis and inflammatory bowel disease? Ann Gastroenterol 2017;30:257-61. [PMID: 28469355 DOI: 10.20524/aog.2017.0126] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
16 Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 51-65 [PMID: 26855812 DOI: 10.4292/wjgpt.v7.i1.51] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
17 Koutsounas I, Pyleris E, Karantanos P, Barbatzas C. First diagnosis of inflammatory bowel disease in a 91-year-old man. Case Rep Gastroenterol 2012;6:790-6. [PMID: 23341803 DOI: 10.1159/000346467] [Reference Citation Analysis]
18 Moran MM, Wessman P, Rolfson O, Bohl DD, Kärrholm J, Keshavarzian A, Sumner DR. The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study. PLoS One 2021;16:e0257310. [PMID: 34735461 DOI: 10.1371/journal.pone.0257310] [Reference Citation Analysis]
19 Adar T, Faleck D, Sasidharan S, Cushing K, Borren NZ, Nalagatla N, Ungaro R, Sy W, Owen SC, Patel A, Cohen BL, Ananthakrishnan AN. Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. Aliment Pharmacol Ther 2019;49:873-9. [PMID: 30773667 DOI: 10.1111/apt.15177] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
20 Kobayashi R, Matsumoto S, Yoshida Y. Tacrolimus Therapy for Three Patients with Elderly-Onset Ulcerative Colitis: Report of Three Cases. Case Rep Gastroenterol 2016;10:392-8. [PMID: 27721723 DOI: 10.1159/000447288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Solanky D, Pardi DS, Loftus EV, Khanna S. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflamm Bowel Dis 2019;25:610-9. [PMID: 30260451 DOI: 10.1093/ibd/izy291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
22 Eder P, Niezgódka A, Krela-Kaźmierczak I, Stawczyk-Eder K, Banasik E, Dobrowolska A. Dietary Support in Elderly Patients with Inflammatory Bowel Disease. Nutrients 2019;11:E1421. [PMID: 31238597 DOI: 10.3390/nu11061421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
23 Salehimarzijarani B, Jalaly NY, Dadvar Z, Hemmasi G, Ashrafi M, Zali M. Long-term quality of life after ileal pouch anal restorative proctocolectomy for ulcerative colitis. Indian J Gastroenterol 2013;32:49-53. [PMID: 23238689 DOI: 10.1007/s12664-012-0284-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Higashiyama M, Sugita A, Koganei K, Wanatabe K, Yokoyama Y, Uchino M, Nagahori M, Naganuma M, Bamba S, Kato S, Takeuchi K, Omori T, Takagi T, Matsumoto S, Nagasaka M, Sagami S, Kitamura K, Katsurada T, Sugimoto K, Takatsu N, Saruta M, Sakurai T, Watanabe K, Nakamura S, Suzuki Y, Hokari R. Management of elderly ulcerative colitis in Japan. J Gastroenterol 2019;54:571-86. [PMID: 31025187 DOI: 10.1007/s00535-019-01580-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
25 Asscher VER, van der Vliet Q, van der Aalst K, van der Aalst A, Brand EC, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, van Tuyl B, Mahmmod N, Maljaars PWJ, Fidder HH; Dutch ICC. Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events. Int J Colorectal Dis 2020;35:2331-8. [PMID: 32860081 DOI: 10.1007/s00384-020-03716-6] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Tawfik A, Flanagan PK, Campbell BJ. Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2014; 20(27): 8751-8763 [PMID: 25083050 DOI: 10.3748/wjg.v20.i27.8751] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
27 Arnott I, Rogler G, Halfvarson J. The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future Perspectives. Inflamm Intest Dis 2018;2:189-99. [PMID: 30221146 DOI: 10.1159/000490053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
28 Ananthakrishnan AN, Shi HY, Tang W, Law CC, Sung JJ, Chan FK, Ng SC. Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease. J Crohns Colitis 2016;10:1224-36. [PMID: 26928965 DOI: 10.1093/ecco-jcc/jjw054] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
29 Butter M, Weiler S, Biedermann L, Scharl M, Rogler G, Bischoff-ferrari HA, Misselwitz B. Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people. Maturitas 2018;110:71-8. [DOI: 10.1016/j.maturitas.2018.01.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
30 Ikeuchi H, Uchino M, Sugita A, Futami K, Fukushima K, Hata K, Koganei K, Kusunoki M, Uchida K, Nezu R, Kimura H, Takahashi K, Itabashi M, Kameyama H, Higashi D, Koyama F, Ueda T, Mizushima T, Suzuki Y. Long-term outcomes following restorative proctocolectomy ileal pouch-anal anastomosis in pediatric ulcerative colitis patients: Multicenter national study in Japan. Ann Gastroenterol Surg 2018;2:428-33. [PMID: 30460346 DOI: 10.1002/ags3.12198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Karaahmet F, Kılıncalp S, Akıncı H, Hamamcı M, Coban S, Yuksel I. A disease affecting all ages: Crohn's disease. J Am Geriatr Soc 2014;62:1200-1. [PMID: 24925563 DOI: 10.1111/jgs.12859] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Matsumoto S, Miyatani H, Yoshida Y. Ulcerative colitis: comparison between elderly and young adult patients and between elderly patients with late-onset and long-standing disease. Dig Dis Sci. 2013;58:1306-1312. [PMID: 23306844 DOI: 10.1007/s10620-012-2517-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
33 Shrestha MP, Taleban S. Management of Ulcerative Colitis in the Elderly. Drugs Aging 2019;36:13-27. [DOI: 10.1007/s40266-018-0611-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Afzali A, Katz S. Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD. Curr Treat Options Gastroenterol 2018;16:289-305. [PMID: 30006766 DOI: 10.1007/s11938-018-0188-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
35 Ali AK, Torosian A, Porter C, Bloomfeld RS, Feldman SR. New onset inflammatory bowel disease in patient treated with secukinumab: Case report and review of literature. Dermatol Ther 2021;:e15151. [PMID: 34609037 DOI: 10.1111/dth.15151] [Reference Citation Analysis]
36 John ES, Katz K, Saxena M, Chokhavatia S, Katz S. Management of Inflammatory Bowel Disease in the Elderly. Curr Treat Options Gastroenterol. 2016;14:285-304. [PMID: 27387455 DOI: 10.1007/s11938-016-0099-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
37 Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, Vasseur F, Dupas JL, Cortot A, Dauchet L, Peyrin-Biroulet L, Lerebours E, Colombel JF, Gower-Rousseau C. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63:423-432. [PMID: 23408350 DOI: 10.1136/gutjnl-2012-303864] [Cited by in Crossref: 188] [Cited by in F6Publishing: 167] [Article Influence: 20.9] [Reference Citation Analysis]
38 Calafat M, Mañosa M, Cañete F, Ricart E, Iglesias E, Calvo M, Rodríguez-Moranta F, Taxonera C, Nos P, Mesonero F, Martín-Arranz MD, Mínguez M, Gisbert JP, García-López S, de Francisco R, Gomollón F, Calvet X, Garcia-Planella E, Rivero M, Martínez-Cadilla J, Argüelles F, Arias L, Cimavilla M, Zabana Y, Domènech E; ENEIDA registry of GETECCU. Increased risk of thiopurine-related adverse events in elderly patients with IBD. Aliment Pharmacol Ther 2019;50:780-8. [PMID: 31429097 DOI: 10.1111/apt.15458] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
39 Velonias G, Conway G, Andrews E, Garber JJ, Khalili H, Yajnik V, Ananthakrishnan AN. Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2017;23:283-8. [PMID: 28079625 DOI: 10.1097/MIB.0000000000001008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Miyoshi J, Matsuura M, Hisamatsu T. Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis. Expert Opin Drug Saf 2021. [PMID: 34511011 DOI: 10.1080/14740338.2021.1980536] [Reference Citation Analysis]